Liver-directed strategies and immunologic consequences of recombinant AAV-mediated cross-correction of glycogen storage disease type II
Publisher: Gainesville, FL
Published: 2004
Language: eng
Number of pages: 166
Subjects: DNA, Recombinant--physiology; DNA, Recombinant--therapeutic use; alpha-Glucosidases--physiology; alpha-Glucosidases--secretion; Glycogen Storage Disease Type II--prevention
Description: <a href="http://uf.catalog.fcla.edu/uf.jsp?st=UF003087838&ix=pm&I=0&V=D&pm=1" rel="nofollow"> http://uf.catalog.fcla.edu/uf.jsp?st=UF003087838&ix=pm&I=0&V=D&pm=1</a>